American College of Cardiology (ACC)

The American College of Cardiology (ACC) is the primary U.S. medical society representing the interests of all cardiology subspecialities. The ACC is very active in setting guidelines for cardiac care, lobbying for supportive government policy and reimbursements, clinician education, managing several key cardiovascular registries and advocating for the transformation of cardiovascular care to improve heart health.

Key takeaways from ACC.25: Advances in cardiovascular science
Former American College of Cardiology president Hadley Wilson, MD, executive vice chair of Atrium Health Sanger Heart and Vascular Institute, explains his main takeaway messages from the ACC 2025 late-breaking trials.
New TAVR research explores adverse outcomes, disease progression in patients with asymptomatic severe AS
Two separate studies at ACC.25 explored data from the EARLY TAVR trial. One analysis included stroke findings that surprised researchers.
Dapagliflozin improves outcomes for elderly TAVR patients with heart failure
The positive data were presented as part of a late-breaking clinical trial at ACC.25 in Chicago. One cardiologist on stage for the presentation said these findings will impact the way he manages certain TAVR patients.
Plant-based diets may help patients with diabetes, heart disease live longer
Researchers focused on data from nearly 78,000 adults with cardiometabolic disorders, sharing their findings at ACC.25 in Chicago.
So far, so good: TAVR comparable to open heart surgery after 5 years in low-risk patients
Michael J. Reardon, MD, shared the highly anticipated data with a large audience at ACC.25 in Chicago. Overall, he said, these five-year findings suggest TAVR with a supra-annular, self-expanding valve is a safe and effective alternative to SAVR.

doctor wrong patient wrong-site surgery medical error malpractice mistake

Use of biolimus-coated balloons during PCI not as effective as paclitaxel devices

Researchers tracked data from more than 200 patients who underwent PCI from August 2020 to July 2022, sharing their findings in JACC: Cardiovascular Interventions.

ACC Vice President Christopher Kramer, MD, FACC, offers an update on the creation of a new cardiovascular board.

Final decision on the creation of a new cardiovascular board expected soon

U.S. cardiology groups have worked together to propose the creation of a new American Board of Cardiovascular Medicine for certifying cardiologists. Now, after many months of waiting, a final decision is expected by the end of February.

ACC President Cathie Biga explains the American College of Cardiology advocacy efforts in Washington D.C. in 2025.

ACC president details key advocacy efforts in cardiology

American College of Cardiology President Cathie Biga, MSN, says Medicare payment reform remains a top priority going forward. Site-neutral payments and improved access to PAD screening are two other issues close to the ACC's heart.

Treating a broken heart: Beta-blockers improve survival in patients with takotsubo syndrome

Takotsubo syndrome, commonly known as “broken heart syndrome,” is often treated as if it was heart failure, but the optimal clinical approach remains a bit of a mystery.

Heart failure patients see benefits from home-based rehab

Many heart failure patients still skip cardiac rehab altogether. Offering a home-based option could potentially help reverse that trend.

More than words: AI takes NLP to the next level to identify signs of heart failure

Previous NLP algorithms for heart failure looked for certain words or phrases, but this updated model makes decisions based on clinical context.

PCI before TAVR linked to better outcomes than performing both at once

Researchers explored data from more than 50,000 TAVR patients who presented with both severe aortic stenosis and stable coronary artery disease, sharing their findings in JACC: Cardiovascular Interventions.

congress money legislation lawmaker bill senate house senator representative

Cardiologist-supported bill to stop ‘harmful’ Medicare cuts returns to Congress

A bipartisan bill designed to block recent Medicare payment cuts has been reintroduced to Congress after failing to pass in 2024. Will things be any different this time around?

American College of Cardiology (ACC)

Key takeaways from ACC.25: Advances in cardiovascular science

New TAVR research explores adverse outcomes, disease progression in patients with asymptomatic severe AS

Dapagliflozin improves outcomes for elderly TAVR patients with heart failure

Plant-based diets may help patients with diabetes, heart disease live longer

So far, so good: TAVR comparable to open heart surgery after 5 years in low-risk patients